Titelia

Funds holding QUINCE THERAPEUTICS INC

ISIN US22053A1079 · United States

Fund holders
8
Of which ETFs
1 7 other funds
Value held
113K $
Share of capital
99.7 % of 1M shares on Aug 7, 2026
FundSharesValueWeight in fundShare of capital
VANGUARD EXTENDED MARKET INDEX FUND VANGUARD INDEX FUNDS 461,47746.8K $0.00 %45.37 %as of Mar 31, 2026
Fidelity Extended Market Index Fund Fidelity Concord Street Trust 238,20129.9K $0.00 %23.42 %as of Feb 28, 2026
iShares Micro-Cap ETF iShares Trust 124,38812.6K $0.00 %12.23 %as of Mar 31, 2026
Fidelity Total Market Index Fund Fidelity Concord Street Trust 85,37110.7K $8.39 %as of Feb 28, 2026
Fidelity Series Total Market Index Fund Fidelity Concord Street Trust 69,4378.7K $6.83 %as of Feb 28, 2026
Fidelity Nasdaq Composite Index Fund Fidelity Concord Street Trust 25,3403.2K $2.49 %as of Feb 28, 2026
1290 VT Micro Cap Portfolio EQ Advisors Trust 8,668878.9 $0.00 %0.85 %as of Mar 31, 2026
Total Stock Market Index Trust John Hancock Variable Insurance Trust 1,096111.1 $0.11 %as of Mar 31, 2026

Download this table: CSV, JSON

Report an error

The funds most exposed to it

The weight is the share of a fund's net assets. The holders table ranks funds by number of shares. This one ranks them by the weight of the company in each fund.

FundWeight in fund
iShares Micro-Cap ETF iShares Trust 0.00 %as of Mar 31, 2026
1290 VT Micro Cap Portfolio EQ Advisors Trust 0.00 %as of Mar 31, 2026
Fidelity Extended Market Index Fund Fidelity Concord Street Trust 0.00 %as of Feb 28, 2026
VANGUARD EXTENDED MARKET INDEX FUND VANGUARD INDEX FUNDS 0.00 %as of Mar 31, 2026

Quarter after quarter

Each row is one quarter of SEC filings, newest first. The change compares each quarter with the one before.

QuarterHoldersChangeSharesChange
2026Q28-71,013,978-57.0 %
2026Q115+32,360,244+24.0 %
2025Q41201,903,425-3.6 %
2025Q31201,974,735+9.6 %
2025Q212+11,802,260+2.2 %
2025Q111-31,763,946+7.2 %
2024Q414-21,644,987-3.7 %
2024Q316-11,708,131+5.9 %
2024Q217-11,612,241+14.1 %
2024Q118-21,413,350+3.6 %
2023Q4201,363,947

Institutional managers

35 managers declare this company to the SEC (Form 13F). The table shows the 25 largest.

ManagerSharesValue
Woodline Partners LP5,200,000527.3K $as of Mar 31, 2026
MILLENNIUM MANAGEMENT LLC2,503,717253.9K $as of Mar 31, 2026
Shay Capital LLC1,772,909179.8K $as of Mar 31, 2026
ACADIAN ASSET MANAGEMENT LLC1,750,862176 $as of Mar 31, 2026
IEQ CAPITAL, LLC600,10560.9K $as of Mar 31, 2026
BlackRock, Inc.473,25948K $as of Mar 31, 2026
STATE STREET CORP248,01125.1K $as of Mar 31, 2026
SUSQUEHANNA INTERNATIONAL GROUP, LLP172,64017.5K $as of Mar 31, 2026
SIMPLEX TRADING, LLC154,09315.6K $as of Mar 31, 2026
Vanguard Personalized Indexing Management, LLC132,66113.5K $as of Mar 31, 2026
TWO SIGMA INVESTMENTS, LP71,2237.2K $as of Mar 31, 2026
NORTHERN TRUST CORP65,9306.7K $as of Mar 31, 2026
Intellectus Partners, LLC53,3125.4K $as of Mar 31, 2026
ADAR1 Capital Management, LLC50,1005.1K $as of Mar 31, 2026
XTX Topco Ltd48,8125K $as of Mar 31, 2026
Nordwand Advisors, LLC20,0002K $as of Mar 31, 2026
Scharf Investments, LLC19,4612K $as of Mar 31, 2026
GOLDMAN SACHS GROUP INC16,0641.6K $as of Mar 31, 2026
Cambridge Investment Research Advisors, Inc.15,2002 $as of Mar 31, 2026
Belvedere Trading LLC13,0801.3K $as of Mar 31, 2026
Alpha Zero LLC13,0001.3K $as of Mar 31, 2026
Mariner, LLC12,6731.3K $as of Mar 31, 2026
NIXON PEABODY TRUST CO11,1261.1K $as of Mar 31, 2026
LPL Financial LLC10,9331.1K $as of Mar 31, 2026
Coyle Financial Counsel LLC10,5091.1K $as of Mar 31, 2026

Declared shareholders of QUINCE THERAPEUTICS INC

There is 1 beneficial ownership filing. These stakes do not add up. An asset manager that files includes its own funds, which already appear among the funds on this page.

ShareholderDeclared stakeShares
Nantahala Capital Management, LLC and 2 others7.52 %4,528,302as of Mar 31, 2026 · SCHEDULE 13G
Cite this page

Titelia. "Funds holding QUINCE THERAPEUTICS INC". https://titelia.com/en/stocks/quince-therapeutics-inc-US22053A1079